Registrieren
Registierung erfolgt in Kürze...
Details werden geladen...
ORIC Pharmaceuticals Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4) | The Manila Times
SOUTH SAN FRANCISCO, Calif. and SAN DIEGO, June 05, 2026 (GLOBE NEWSWIRE) -- ORIC Pharmaceuticals, Inc. (Nasdaq:ORIC), a clinical stage oncology company focused on developing treatments that address mechanisms of therapeutic resistance, today announced that on June 1, 2026 (the 'Grant Date”), ORIC granted a total of 34,800 non-qualified stock options and 5,900 restricted stock units to two new non-executive employees who began their employment with ORIC in May 2026.
Ähnliche Seiten
Xenon Pharmaceuticals Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) | The Manila Times
https://www.manilatimes.net/2026/05/30/tmt-newswire/globenewswire/xenon-pharmaceuticals-reports-inducement-grants-under-nasdaq-listing-rule-5635c4/2354842EyePoint Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4) | The Manila Times
https://www.manilatimes.net/2026/05/18/tmt-newswire/globenewswire/eyepoint-reports-inducement-grants-under-nasdaq-listing-rule-5635c4/2346093Ultragenyx Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) | The Manila Times
https://www.manilatimes.net/2026/05/23/tmt-newswire/globenewswire/ultragenyx-reports-inducement-grant-under-nasdaq-listing-rule-5635c4/2350373Vor Bio Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) | The Manila Times
https://www.manilatimes.net/2026/06/02/tmt-newswire/globenewswire/vor-bio-reports-inducement-grant-under-nasdaq-listing-rule-5635c4/2356286Arcutis Biotherapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) | The Manila Times
https://www.manilatimes.net/2026/06/06/tmt-newswire/globenewswire/arcutis-biotherapeutics-reports-inducement-grants-under-nasdaq-listing-rule-5635c4/2359847